Tralokinumab improves clinical scores in adolescents with severe atopic dermatitis: A real-life multicentric observational study.

De Greef, Axel;Ghislain, Pierre-Dominique;de Montjoye, Laurence;Adriaenssens, Kristel;Baeck, Marie;et.al.
(2024) Journal of the European Academy of Dermatology and Venereology — Vol. 38, n° 3, p. e288-e290 (2024)

Files

2023_De_Greef_J_Eur_Acad_Dermatol_Venereol.pdf
  • Open Access
  • Adobe PDF
  • 736.8 KB
Download

Details

Authors
Show more
Abstract
Dear Editor,Atopic dermatitis (AD) usually develops during early child-hood but may continue into adolescence. The exact preva-lence of AD in adolescents remains unknown but recent longitudinal studies indicate a similar prevalence in child-hood and adolescence. [...]
Affiliations

Citations

  • APA
  • Chicago
  • FWB

De Greef, A., Ghislain, P.-D., de Montjoye, L., Adriaenssens, K., Bulinckx, A., Colmant, C., Cuvelier, M., Deleu, H., Goeteyn, M., Janssens, P., Kul, A., Roquet-Gravy, C., Stragier, I., & Baeck, M. (2024). Tralokinumab improves clinical scores in adolescents with severe atopic dermatitis: A real-life multicentric observational study. Journal of the European Academy of Dermatology and Venereology, 38(3), e288-e290. https://doi.org/10.1111/jdv.19605 (Original work published 2024)